Quadrant Capital Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $668K | Buy |
|
|||||
|
2025
Q1 | $778K | Buy |
|
|||||
|
2024
Q4 | $117K | Buy |
|
|||||
|
2024
Q3 | $78.6K | Buy |
|
|||||
|
2024
Q2 | $35.5K | Buy |
|
|||||
|
2024
Q1 | $14.4K | Buy |
|
|||||
|
2023
Q4 | $14.6K | Buy |
|
|||||
|
2023
Q3 | $11.7K | Sell |
|
|||||
|
2023
Q2 | $39.8K | Sell |
|
|||||
|
2023
Q1 | $50.7K | Buy |
|
|||||
|
2022
Q4 | $23.9K | Sell |
|
|||||
|
2022
Q3 | $21K | Sell |
|
|||||
|
2022
Q2 | $29K | Buy |
|
|||||
|
2022
Q1 | $9K | Sell |
|
|||||
|
2021
Q4 | $21K | Buy |
|
|||||
|
2021
Q3 | $18K | Sell |
|
|||||
|
2021
Q2 | $20K | Sell |
|
|||||
|
2021
Q1 | $26K | Buy |
|
|||||
|
2020
Q4 | $21K | Sell |
|
|||||
|
2020
Q3 | $19K | Sell |
|
|||||
|
2020
Q2 | $95K | Sell |
|
|||||
|
2020
Q1 | $137K | Buy |
|
|||||
|
2019
Q4 | $41K | Sell |
|
|||||
|
2019
Q3 | $62K | Sell |
|
|||||
|
2019
Q2 | $156K | Buy |
|
|||||
|
2019
Q1 | $105K | Buy |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $38K | Hold |
|
|||||
|
2018
Q2 | $36K | Buy |
|
|||||
|
2018
Q1 | $21K | Sell |
|
|||||
|
2017
Q4 | $27K | Sell |
|
|||||
|
2017
Q3 | $36K | Buy |
|
|||||
|
2017
Q2 | $31K | Buy |
|
|||||
|
2017
Q1 | $23K | Buy |
|
|||||
|
2016
Q4 | $17K | Sell |
|
|||||
|
2016
Q3 | $26K | Hold |
|
|||||
|
2016
Q2 | $22K | Buy |
|
|||||
|
2016
Q1 | $9K | Buy |
|
|||||
|
2015
Q4 | $8K | Buy |
|
|||||
|
2015
Q3 | $8K | Buy |
|